ASSERTIO THERAPEUTICS, INC. Earnings Per Share, Basic and Diluted
ASSERTIO THERAPEUTICS, INC. reported Earnings Per Share, Basic and Diluted of -$1.63 per share for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-01.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2018-03-01
- ASSERTIO THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2017-12-31 was -$0.52.
- ASSERTIO THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2017-09-30 was -$0.25.
- ASSERTIO THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2017-06-30 was -$0.43.
- ASSERTIO THERAPEUTICS, INC. earnings per share, basic and diluted for the quarter ending 2017-03-31 was -$0.43.
- ASSERTIO THERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2017 was -$1.63.
- ASSERTIO THERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2016 was -$1.45.
- ASSERTIO THERAPEUTICS, INC. earnings per share, basic and diluted for fiscal 2015 was -$1.26.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2019-12-31 | -$3.07 derived: net income ÷ weighted average shares · filed 2020-03-10 | |||
| 2018-12-31 | $0.58 derived: net income ÷ weighted average shares · filed 2020-03-10 | |||
| 2017-12-31 | -$0.52 derived: net income ÷ weighted average shares · filed 2020-03-10 | -$0.78 derived: net income ÷ weighted average shares · filed 2020-03-10 | -$1.20 derived: net income ÷ weighted average shares · filed 2020-03-10 | -$1.63 10-K · filed 2018-03-01 |
| 2017-09-30 | -$0.25 10-Q · filed 2017-11-09 | -$0.68 derived: net income ÷ weighted average shares · filed 2019-03-11 | -$1.11 10-Q · filed 2017-11-09 | -$1.82 derived: net income ÷ weighted average shares · filed 2019-03-11 |
| 2017-06-30 | -$0.43 10-Q · filed 2017-08-07 | -$0.86 10-Q · filed 2017-08-07 | -$1.57 derived: net income ÷ weighted average shares · filed 2019-03-11 | -$1.79 derived: net income ÷ weighted average shares · filed 2019-03-11 |
| 2017-03-31 | -$0.43 10-Q · filed 2017-05-10 | -$1.15 derived: net income ÷ weighted average shares · filed 2019-03-11 | -$1.36 derived: net income ÷ weighted average shares · filed 2019-03-11 | -$1.53 derived: net income ÷ weighted average shares · filed 2019-03-11 |
| 2016-12-31 | -$0.72 derived: net income ÷ weighted average shares · filed 2019-03-11 | -$0.93 derived: net income ÷ weighted average shares · filed 2019-03-11 | -$1.10 derived: net income ÷ weighted average shares · filed 2019-03-11 | -$1.45 10-K · filed 2018-03-01 |
| 2016-09-30 | -$0.21 10-Q · filed 2017-11-09 | -$0.38 derived: net income ÷ weighted average shares · filed 2018-03-01 | -$0.73 10-Q · filed 2017-11-09 | -$1.23 derived: net income ÷ weighted average shares · filed 2018-03-01 |
| 2016-06-30 | -$0.17 10-Q · filed 2017-08-07 | -$0.52 10-Q · filed 2017-08-07 | -$1.02 derived: net income ÷ weighted average shares · filed 2018-03-01 | -$1.22 derived: net income ÷ weighted average shares · filed 2018-03-01 |
| 2016-03-31 | -$0.34 10-Q · filed 2017-05-10 | -$0.85 derived: net income ÷ weighted average shares · filed 2018-03-01 | -$1.05 derived: net income ÷ weighted average shares · filed 2018-03-01 | -$1.41 derived: net income ÷ weighted average shares · filed 2018-03-01 |
| 2015-12-31 | -$0.51 derived: net income ÷ weighted average shares · filed 2018-03-01 | -$0.70 derived: net income ÷ weighted average shares · filed 2018-03-01 | -$1.06 derived: net income ÷ weighted average shares · filed 2018-03-01 | -$1.26 10-K · filed 2018-03-01 |
| 2015-09-30 | -$0.20 10-Q · filed 2016-11-07 | -$0.56 derived: net income ÷ weighted average shares · filed 2017-02-24 | -$0.75 10-Q · filed 2016-11-07 | |
| 2015-06-30 | -$0.36 10-Q · filed 2016-08-03 | -$0.56 10-Q · filed 2016-08-03 |